skip to Main Content

Epidermal Growth Factor Receptor and Its Role in Pancreatic Cancer Treatment Mediated by Nanoparticles

Newsfeed image, light gray text on dark gray background
Pancreatic adenocarcinoma (PDAC) is a disease with a high incidence and a dreary prognosis.

Its lack of symptomatology and late diagnosis contribute to the dearth and inefficiency of therapeutic schemes. Studies show that overexpressed epidermal growth factor receptor (EGFR) is a common occurrence, linking this to the progression of pancreatic cancer, although the association between its expression and the survival rate is rather controversial. Read more . . .

Back To Top